nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—SLC22A6—Glyburide—gestational diabetes	0.294	0.54	CbGbCtD
Sulindac—ALB—Glyburide—gestational diabetes	0.25	0.46	CbGbCtD
Sulindac—Acute psychosis—Glyburide—gestational diabetes	0.0446	0.21	CcSEcCtD
Sulindac—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.019	0.0894	CcSEcCtD
Sulindac—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.0123	0.058	CcSEcCtD
Sulindac—AKR1B1—Metabolism of steroid hormones and vitamin D—CYP19A1—gestational diabetes	0.012	0.0874	CbGpPWpGaD
Sulindac—AKR1B1—islet of Langerhans—gestational diabetes	0.0101	0.095	CbGeAlD
Sulindac—AKR1B1—embryo—gestational diabetes	0.00973	0.0919	CbGeAlD
Sulindac—PTGS2—Nicotinamide salvaging—NAMPT—gestational diabetes	0.00824	0.0599	CbGpPWpGaD
Sulindac—Cholestasis—Glyburide—gestational diabetes	0.00794	0.0374	CcSEcCtD
Sulindac—PPARD—islet of Langerhans—gestational diabetes	0.00791	0.0747	CbGeAlD
Sulindac—MAPK3—embryo—gestational diabetes	0.00705	0.0666	CbGeAlD
Sulindac—MAPK3—Nongenotropic Androgen signaling—SHBG—gestational diabetes	0.00701	0.0509	CbGpPWpGaD
Sulindac—AKR1B1—uterus—gestational diabetes	0.00656	0.062	CbGeAlD
Sulindac—AKR1B1—adipose tissue—gestational diabetes	0.00641	0.0606	CbGeAlD
Sulindac—Aplastic anaemia—Glyburide—gestational diabetes	0.00566	0.0267	CcSEcCtD
Sulindac—MAPK3—Signaling by Leptin—LEPR—gestational diabetes	0.00536	0.039	CbGpPWpGaD
Sulindac—AKR1B1—vagina—gestational diabetes	0.00533	0.0504	CbGeAlD
Sulindac—PPARD—adipose tissue—gestational diabetes	0.00504	0.0477	CbGeAlD
Sulindac—AKR1B1—head—gestational diabetes	0.00493	0.0465	CbGeAlD
Sulindac—Vascular purpura—Glyburide—gestational diabetes	0.00489	0.0231	CcSEcCtD
Sulindac—Hepatic failure—Glyburide—gestational diabetes	0.00487	0.023	CcSEcCtD
Sulindac—Haemolytic anaemia—Glyburide—gestational diabetes	0.00485	0.0229	CcSEcCtD
Sulindac—MAPK3—uterus—gestational diabetes	0.00475	0.0449	CbGeAlD
Sulindac—MAPK3—adipose tissue—gestational diabetes	0.00465	0.0439	CbGeAlD
Sulindac—Visual disturbance—Glyburide—gestational diabetes	0.00462	0.0218	CcSEcCtD
Sulindac—Renal impairment—Glyburide—gestational diabetes	0.0046	0.0217	CcSEcCtD
Sulindac—Purpura—Glyburide—gestational diabetes	0.00454	0.0214	CcSEcCtD
Sulindac—Arthritis—Glyburide—gestational diabetes	0.0045	0.0212	CcSEcCtD
Sulindac—PTGS2—Nicotinate metabolism—NAMPT—gestational diabetes	0.00439	0.0319	CbGpPWpGaD
Sulindac—PPARD—vagina—gestational diabetes	0.00419	0.0396	CbGeAlD
Sulindac—PPARD—Adipogenesis—RETN—gestational diabetes	0.00418	0.0304	CbGpPWpGaD
Sulindac—PPARD—head—gestational diabetes	0.00387	0.0366	CbGeAlD
Sulindac—MAPK3—vagina—gestational diabetes	0.00386	0.0365	CbGeAlD
Sulindac—PPARD—Nuclear Receptors—AR—gestational diabetes	0.00379	0.0275	CbGpPWpGaD
Sulindac—Eosinophilia—Glyburide—gestational diabetes	0.00375	0.0177	CcSEcCtD
Sulindac—Pancreatitis—Glyburide—gestational diabetes	0.00371	0.0175	CcSEcCtD
Sulindac—Sweating increased—Glyburide—gestational diabetes	0.00369	0.0174	CcSEcCtD
Sulindac—Pancytopenia—Glyburide—gestational diabetes	0.00359	0.0169	CcSEcCtD
Sulindac—MAPK3—head—gestational diabetes	0.00357	0.0337	CbGeAlD
Sulindac—Photosensitivity reaction—Glyburide—gestational diabetes	0.00345	0.0163	CcSEcCtD
Sulindac—Jaundice—Glyburide—gestational diabetes	0.00329	0.0155	CcSEcCtD
Sulindac—AKR1B1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00317	0.023	CbGpPWpGaD
Sulindac—Agranulocytosis—Glyburide—gestational diabetes	0.00315	0.0148	CcSEcCtD
Sulindac—Hepatitis—Glyburide—gestational diabetes	0.00303	0.0143	CcSEcCtD
Sulindac—PPARD—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00299	0.0217	CbGpPWpGaD
Sulindac—Visual impairment—Glyburide—gestational diabetes	0.00292	0.0138	CcSEcCtD
Sulindac—Alopecia—Glyburide—gestational diabetes	0.00268	0.0126	CcSEcCtD
Sulindac—MAPK3—FSH signaling pathway—CYP19A1—gestational diabetes	0.00261	0.019	CbGpPWpGaD
Sulindac—PTGDR2—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00254	0.0184	CbGpPWpGaD
Sulindac—Vision blurred—Glyburide—gestational diabetes	0.00248	0.0117	CcSEcCtD
Sulindac—Anaemia—Glyburide—gestational diabetes	0.00244	0.0115	CcSEcCtD
Sulindac—Angioedema—Glyburide—gestational diabetes	0.00241	0.0114	CcSEcCtD
Sulindac—Leukopenia—Glyburide—gestational diabetes	0.00236	0.0111	CcSEcCtD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00236	0.0171	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—LEPR—gestational diabetes	0.0023	0.0167	CbGpPWpGaD
Sulindac—Convulsion—Glyburide—gestational diabetes	0.00228	0.0108	CcSEcCtD
Sulindac—MAPK3—Nongenotropic Androgen signaling—AR—gestational diabetes	0.00228	0.0165	CbGpPWpGaD
Sulindac—Myalgia—Glyburide—gestational diabetes	0.00224	0.0106	CcSEcCtD
Sulindac—Arthralgia—Glyburide—gestational diabetes	0.00224	0.0106	CcSEcCtD
Sulindac—Oedema—Glyburide—gestational diabetes	0.00215	0.0101	CcSEcCtD
Sulindac—Shock—Glyburide—gestational diabetes	0.00212	0.00998	CcSEcCtD
Sulindac—Thrombocytopenia—Glyburide—gestational diabetes	0.00211	0.00993	CcSEcCtD
Sulindac—Hyperhidrosis—Glyburide—gestational diabetes	0.00208	0.00981	CcSEcCtD
Sulindac—Anorexia—Glyburide—gestational diabetes	0.00205	0.00967	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00202	0.0147	CbGpPWpGaD
Sulindac—Hypotension—Glyburide—gestational diabetes	0.00201	0.00948	CcSEcCtD
Sulindac—PPARD—Adipogenesis—NAMPT—gestational diabetes	0.002	0.0146	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00196	0.00924	CcSEcCtD
Sulindac—Paraesthesia—Glyburide—gestational diabetes	0.00193	0.00911	CcSEcCtD
Sulindac—Dyspnoea—Glyburide—gestational diabetes	0.00192	0.00904	CcSEcCtD
Sulindac—Dyspepsia—Glyburide—gestational diabetes	0.00189	0.00893	CcSEcCtD
Sulindac—PTGS2—islet of Langerhans—gestational diabetes	0.00189	0.0179	CbGeAlD
Sulindac—MAPK3—Signaling by Leptin—LEP—gestational diabetes	0.00188	0.0137	CbGpPWpGaD
Sulindac—Decreased appetite—Glyburide—gestational diabetes	0.00187	0.00882	CcSEcCtD
Sulindac—PTGS2—embryo—gestational diabetes	0.00183	0.0173	CbGeAlD
Sulindac—Feeling abnormal—Glyburide—gestational diabetes	0.00177	0.00836	CcSEcCtD
Sulindac—Gastrointestinal pain—Glyburide—gestational diabetes	0.00176	0.00829	CcSEcCtD
Sulindac—Urticaria—Glyburide—gestational diabetes	0.00171	0.00806	CcSEcCtD
Sulindac—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—gestational diabetes	0.00171	0.0124	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—ADIPOQ—gestational diabetes	0.00164	0.0119	CbGpPWpGaD
Sulindac—Hypersensitivity—Glyburide—gestational diabetes	0.00159	0.00747	CcSEcCtD
Sulindac—AKR1B1—Metabolism—GGCT—gestational diabetes	0.00158	0.0115	CbGpPWpGaD
Sulindac—Asthenia—Glyburide—gestational diabetes	0.00154	0.00728	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—MTNR1B—gestational diabetes	0.00154	0.0112	CbGpPWpGaD
Sulindac—Pruritus—Glyburide—gestational diabetes	0.00152	0.00718	CcSEcCtD
Sulindac—Diarrhoea—Glyburide—gestational diabetes	0.00147	0.00694	CcSEcCtD
Sulindac—CYP1A1—uterus—gestational diabetes	0.00147	0.0139	CbGeAlD
Sulindac—CYP1A1—adipose tissue—gestational diabetes	0.00144	0.0136	CbGeAlD
Sulindac—AKR1B1—Metabolism—GLS2—gestational diabetes	0.00138	0.01	CbGpPWpGaD
Sulindac—Vomiting—Glyburide—gestational diabetes	0.00137	0.00645	CcSEcCtD
Sulindac—Rash—Glyburide—gestational diabetes	0.00136	0.0064	CcSEcCtD
Sulindac—Dermatitis—Glyburide—gestational diabetes	0.00136	0.00639	CcSEcCtD
Sulindac—Headache—Glyburide—gestational diabetes	0.00135	0.00635	CcSEcCtD
Sulindac—PTGS1—uterus—gestational diabetes	0.00129	0.0122	CbGeAlD
Sulindac—PTGS1—Biological oxidations—GGCT—gestational diabetes	0.00128	0.00929	CbGpPWpGaD
Sulindac—Nausea—Glyburide—gestational diabetes	0.00128	0.00602	CcSEcCtD
Sulindac—PTGS1—adipose tissue—gestational diabetes	0.00126	0.0119	CbGeAlD
Sulindac—PTGS2—uterus—gestational diabetes	0.00123	0.0117	CbGeAlD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00123	0.00896	CbGpPWpGaD
Sulindac—PTGS2—adipose tissue—gestational diabetes	0.00121	0.0114	CbGeAlD
Sulindac—CYP1A1—vagina—gestational diabetes	0.0012	0.0113	CbGeAlD
Sulindac—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.00116	0.00845	CbGpPWpGaD
Sulindac—CYP1A1—head—gestational diabetes	0.0011	0.0104	CbGeAlD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—MBL2—gestational diabetes	0.00107	0.00779	CbGpPWpGaD
Sulindac—PTGS1—vagina—gestational diabetes	0.00105	0.00993	CbGeAlD
Sulindac—PPARD—Adipogenesis—LEP—gestational diabetes	0.00102	0.0074	CbGpPWpGaD
Sulindac—MAPK3—Negative regulation of FGFR signaling—FGF2—gestational diabetes	0.00101	0.00737	CbGpPWpGaD
Sulindac—PTGS2—vagina—gestational diabetes	0.001	0.00949	CbGeAlD
Sulindac—MAPK3—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.000996	0.00724	CbGpPWpGaD
Sulindac—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000982	0.00713	CbGpPWpGaD
Sulindac—PTGS1—head—gestational diabetes	0.00097	0.00917	CbGeAlD
Sulindac—MAPK3—FRS2-mediated cascade—FGF2—gestational diabetes	0.000939	0.00683	CbGpPWpGaD
Sulindac—PTGS2—head—gestational diabetes	0.000927	0.00876	CbGeAlD
Sulindac—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000901	0.00655	CbGpPWpGaD
Sulindac—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.0009	0.00654	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000869	0.00631	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—FGF2—gestational diabetes	0.000848	0.00616	CbGpPWpGaD
Sulindac—PTGS1—Overview of nanoparticle effects—TNF—gestational diabetes	0.000839	0.0061	CbGpPWpGaD
Sulindac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000839	0.00609	CbGpPWpGaD
Sulindac—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000838	0.00609	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—GCK—gestational diabetes	0.000828	0.00601	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—LEP—gestational diabetes	0.000807	0.00586	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000789	0.00573	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.000786	0.00571	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—NAMPT—gestational diabetes	0.000756	0.00549	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—GCK—gestational diabetes	0.000751	0.00546	CbGpPWpGaD
Sulindac—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000728	0.00529	CbGpPWpGaD
Sulindac—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000718	0.00522	CbGpPWpGaD
Sulindac—MAPK3—Integrins in angiogenesis—FGF2—gestational diabetes	0.000705	0.00512	CbGpPWpGaD
Sulindac—PTGS2—Overview of nanoparticle effects—TNF—gestational diabetes	0.000666	0.00484	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000594	0.00431	CbGpPWpGaD
Sulindac—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00059	0.00429	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—LEPR—gestational diabetes	0.000589	0.00428	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000574	0.00417	CbGpPWpGaD
Sulindac—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000574	0.00417	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GGCT—gestational diabetes	0.000572	0.00415	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—LEP—gestational diabetes	0.000562	0.00408	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.00056	0.00407	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—FGF2—gestational diabetes	0.000555	0.00403	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—CYP19A1—gestational diabetes	0.000549	0.00399	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.00054	0.00393	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—FGF2—gestational diabetes	0.000539	0.00392	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—FGF2—gestational diabetes	0.000535	0.00388	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—TNF—gestational diabetes	0.000534	0.00388	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000531	0.00386	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—FGF2—gestational diabetes	0.000521	0.00378	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—FGF2—gestational diabetes	0.000521	0.00378	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—AR—gestational diabetes	0.000517	0.00376	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—TNF—gestational diabetes	0.000516	0.00375	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GLS2—gestational diabetes	0.0005	0.00363	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—TNF—gestational diabetes	0.000486	0.00353	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000478	0.00348	CbGpPWpGaD
Sulindac—PPARD—Adipogenesis—TNF—gestational diabetes	0.000471	0.00342	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MTNR1B—gestational diabetes	0.000466	0.00339	CbGpPWpGaD
Sulindac—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000464	0.00337	CbGpPWpGaD
Sulindac—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000458	0.00333	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RBP4—gestational diabetes	0.000454	0.0033	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000447	0.00325	CbGpPWpGaD
Sulindac—PTGS1—Biological oxidations—CYP19A1—gestational diabetes	0.000445	0.00323	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000433	0.00314	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000414	0.003	CbGpPWpGaD
Sulindac—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000376	0.00273	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—FGF2—gestational diabetes	0.00037	0.00269	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TNF—gestational diabetes	0.000358	0.0026	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000354	0.00257	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000354	0.00257	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—GCK—gestational diabetes	0.000349	0.00254	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGF2—gestational diabetes	0.000348	0.00253	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MBL2—gestational diabetes	0.000343	0.00249	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000341	0.00248	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—LEP—gestational diabetes	0.000334	0.00243	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—FGF2—gestational diabetes	0.000333	0.00242	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGF2—gestational diabetes	0.000331	0.00241	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—FGF2—gestational diabetes	0.000329	0.00239	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000328	0.00239	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—FGF2—gestational diabetes	0.000328	0.00238	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000317	0.0023	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000316	0.0023	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000313	0.00228	CbGpPWpGaD
Sulindac—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000309	0.00225	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGF2—gestational diabetes	0.000308	0.00224	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000308	0.00224	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000308	0.00224	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	0.000307	0.00223	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGF2—gestational diabetes	0.000306	0.00222	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000303	0.0022	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—FGF2—gestational diabetes	0.000302	0.00219	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000292	0.00212	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000291	0.00212	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000291	0.00212	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00029	0.00211	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—ADIPOQ—gestational diabetes	0.000288	0.00209	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000281	0.00204	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000274	0.00199	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NAMPT—gestational diabetes	0.000274	0.00199	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000273	0.00199	CbGpPWpGaD
Sulindac—PPARD—Metabolism—GCK—gestational diabetes	0.000272	0.00198	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TNF—gestational diabetes	0.00026	0.00189	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AR—gestational diabetes	0.000249	0.00181	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000246	0.00179	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000245	0.00178	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000228	0.00166	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—MTNR1B—gestational diabetes	0.000226	0.00164	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GGCT—gestational diabetes	0.000219	0.00159	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGF2—gestational diabetes	0.00021	0.00153	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—LEP—gestational diabetes	0.000207	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MBL2—gestational diabetes	0.0002	0.00145	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.0002	0.00145	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—gestational diabetes	0.000199	0.00145	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CYP19A1—gestational diabetes	0.000199	0.00145	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000197	0.00143	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—gestational diabetes	0.000196	0.00142	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—gestational diabetes	0.000195	0.00142	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GLS2—gestational diabetes	0.000191	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Disease—RBP4—gestational diabetes	0.000186	0.00135	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000186	0.00135	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000186	0.00135	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—LEP—gestational diabetes	0.000179	0.0013	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000177	0.00128	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GGCT—gestational diabetes	0.000174	0.00126	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000173	0.00125	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000171	0.00124	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEPR—gestational diabetes	0.000169	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Disease—NAMPT—gestational diabetes	0.000167	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Disease—GCK—gestational diabetes	0.000166	0.00121	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	0.000158	0.00115	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF2—gestational diabetes	0.000157	0.00114	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—gestational diabetes	0.000154	0.00112	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GGCT—gestational diabetes	0.000154	0.00112	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GLS2—gestational diabetes	0.000152	0.0011	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000143	0.00104	CbGpPWpGaD
Sulindac—ALB—Metabolism—GGCT—gestational diabetes	0.00014	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—FGF2—gestational diabetes	0.000136	0.000986	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000136	0.000985	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GLS2—gestational diabetes	0.000135	0.000978	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MTNR1B—gestational diabetes	0.000134	0.000972	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RBP4—gestational diabetes	0.00013	0.000947	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AR—gestational diabetes	0.000127	0.000923	CbGpPWpGaD
Sulindac—ALB—Metabolism—GLS2—gestational diabetes	0.000123	0.000892	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00012	0.000875	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF2—gestational diabetes	0.00012	0.000871	CbGpPWpGaD
Sulindac—PTGS2—Disease—RBP4—gestational diabetes	0.000111	0.000804	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00011	0.000797	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000105	0.000764	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NAMPT—gestational diabetes	0.000105	0.000761	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GCK—gestational diabetes	0.000104	0.000756	CbGpPWpGaD
Sulindac—PTGS2—Disease—NAMPT—gestational diabetes	9.93e-05	0.000721	CbGpPWpGaD
Sulindac—PTGS2—Disease—GCK—gestational diabetes	9.86e-05	0.000717	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GGCT—gestational diabetes	9.82e-05	0.000714	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GLS2—gestational diabetes	8.59e-05	0.000624	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NAMPT—gestational diabetes	8.31e-05	0.000604	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—gestational diabetes	8.26e-05	0.0006	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GCK—gestational diabetes	8.26e-05	0.0006	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	7.67e-05	0.000558	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP19A1—gestational diabetes	7.61e-05	0.000553	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NAMPT—gestational diabetes	7.38e-05	0.000536	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCK—gestational diabetes	7.33e-05	0.000533	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF2—gestational diabetes	6.98e-05	0.000507	CbGpPWpGaD
Sulindac—ALB—Metabolism—NAMPT—gestational diabetes	6.73e-05	0.000489	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCK—gestational diabetes	6.68e-05	0.000486	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF2—gestational diabetes	6.44e-05	0.000468	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP19A1—gestational diabetes	6.04e-05	0.000439	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—gestational diabetes	5.94e-05	0.000432	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP19A1—gestational diabetes	5.36e-05	0.000389	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP19A1—gestational diabetes	4.89e-05	0.000355	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NAMPT—gestational diabetes	4.7e-05	0.000342	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCK—gestational diabetes	4.67e-05	0.00034	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF2—gestational diabetes	4.51e-05	0.000328	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF2—gestational diabetes	3.83e-05	0.000278	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP19A1—gestational diabetes	3.42e-05	0.000248	CbGpPWpGaD
